Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jagsonpal Pharmaceuticals has informed the stock exchanges that its trading window will be closed for designated persons and their immediate relatives starting April 1, 2026. The window will reopen 48 hours after the company declares its audited financial results for the quarter and financial year ended March 31, 2026. The exact date of the board meeting to approve these annual results has not yet been announced and will be communicated later. This is a routine compliance step required under SEBI's insider trading regulations to prevent insiders from trading shares ahead of results.
This is a standard regulatory filing with no direct impact on shareholders. It does signal that audited FY26 results will be announced in the coming weeks, which is the next catalyst for the stock.